WallStSmart

Coca-Cola Femsa SAB de CV ADR (KOF)vsNu Skin Enterprises Inc (NUS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola Femsa SAB de CV ADR generates 21438% more annual revenue ($296.20B vs $1.38B). KOF leads profitability with a 8.1% profit margin vs -15.7%. NUS appears more attractively valued with a PEG of 0.78. KOF earns a higher WallStSmart Score of 54/100 (C-).

KOF

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 6.5Value: 5.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.47

NUS

Hold

47

out of 100

Grade: D+

Growth: 2.0Profit: 4.5Value: 7.7Quality: 7.5
Piotroski: 5/9Altman Z: 4.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KOFUndervalued (+55.3%)

Margin of Safety

+55.3%

Fair Value

$251.68

Current Price

$113.14

$138.54 discount

UndervaluedFair: $251.68Overvalued
NUSUndervalued (+53.3%)

Margin of Safety

+53.3%

Fair Value

$21.79

Current Price

$4.79

$17.00 discount

UndervaluedFair: $21.79Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KOF2 strengths · Avg: 8.0/10
Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$8.86B8/10

Generating 8.9B in free cash flow

NUS3 strengths · Avg: 9.3/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
4.4510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.788/10

Growing faster than its price suggests

Areas to Watch

KOF3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
19.722/10

Expensive relative to growth rate

NUS4 concerns · Avg: 2.5/10
Market CapQuality
$230.73M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.9%3/10

ROE of 6.9% — below average capital efficiency

Revenue GrowthGrowth
-17.1%2/10

Revenue declined 17.1%

EPS GrowthGrowth
-98.2%2/10

Earnings declined 98.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : KOF

The strongest argument for KOF centers on Price/Book, Free Cash Flow.

Bull Case : NUS

The strongest argument for NUS centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bear Case : KOF

The primary concerns for KOF are Revenue Growth, Piotroski F-Score, PEG Ratio.

Bear Case : NUS

The primary concerns for NUS are Market Cap, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

KOF profiles as a value stock while NUS is a turnaround play — different risk/reward profiles.

NUS carries more volatility with a beta of 0.97 — expect wider price swings.

KOF is growing revenue faster at 4.7% — sustainability is the question.

KOF generates stronger free cash flow (8.9B), providing more financial flexibility.

Bottom Line

KOF scores higher overall (54/100 vs 47/100). NUS offers better value entry with a 53.3% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola Femsa SAB de CV ADR

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola FEMSA, SAB de CV, a franchise bottler, produces, markets, sells and distributes Coca-Cola brand beverages. The company is headquartered in Mexico City, Mexico.

Visit Website →

Nu Skin Enterprises Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Nu Skin Enterprises, Inc. develops and distributes wellness and personal care products globally. The company is headquartered in Provo, Utah.

Visit Website →

Want to dig deeper into these stocks?